Accordingly, CLEC2D expression significantly increased in primary tumors compared to normal tissue, and high CLEC2D mRNA levels were strongly associated with lower survival rates in HPV-negative HNSCC patients. Here, CLEC2D is linked to head and neck squamous cell carcinoma.